NRX Pharmaceuticals, Inc. (NRXP)
2.615
+0.02
(+0.58%)
USD |
NASDAQ |
Dec 30, 10:30
NRX Pharmaceuticals EPS Diluted (Quarterly): -0.2649 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Synergy CHC Corp. | 0.0124 |
| Acurx Pharmaceuticals, Inc. | -1.226 |
| IGC Pharma, Inc. | -0.0201 |
| NeOnc Technologies Holdings, Inc. | -0.4485 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.89M |
| Revenue (Quarterly) | 0.242M |
| Total Expenses (Quarterly) | 6.132M |
| Enterprise Value | 76.28M |
| Gross Profit Margin (Quarterly) | 42.98% |
| Profit Margin (Quarterly) | -2.43K% |
| Earnings Yield | -90.02% |
| Normalized Earnings Yield | -45.44 |